Protective role of 17β-estradiol on medulloblastoma development in Patched1 heterozygous mice

International Journal of Cancer

Volumn 127, Issue 12, 2010, Pages 2749-2757

  Mancuso, Mariateresa ^a   Leonardi, Simona ^a   Ceccarelli, Manuela ^a   Pasquali, Emanuela ^a   Stefano, Ilaria De ^b   Prisco, Maria Grazia ^b   Rebessi, Simonetta ^a   Tanori, Mirella ^a   Scambia, Giovanni ^b   Majo, Vincenzo Di ^a   Pazzaglia, Simonetta ^a   Saran, Anna ^a   Gallo, Daniela ^b  

^a ENEA   (Italy)

^b UniversitàCattolica Del Sacro Cuore ^*  (Italy)

Author keywords

ER ; ER ; IGF I; Ptch1; Radiation

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ESTROGEN THERAPY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; MEDULLOBLASTOMA; MOUSE; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ANIMALS; BLOTTING, WESTERN; CEREBELLAR NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HETEROZYGOTE; IMMUNOENZYME TECHNIQUES; INSULIN-LIKE GROWTH FACTOR I; MEDULLOBLASTOMA; MICE; MICE, KNOCKOUT; OVARIECTOMY; RECEPTORS, CELL SURFACE; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; WHOLE-BODY IRRADIATION;

EID: 78249281351     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25293     Document Type: Article

References (44)

1. Gurney JG, Smith MA, Bunin GR,. CNS and miscellaneous intracranial and intraspinal neoplasms. SEER Pediatric Monograph. Bethesda, MD: National Cancer Institute, 1999. 51 -63.
2. Brandes AA, Paris MK,. Review of the prognostic factors in medulloblastoma of children and adults. Crit Rev Oncol Hematol 2004; 50: 121 -8.
3. Polkinghorn WR, Tarbell NJ,. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Oncol 2007; 4: 295 -304.
4. Gilbertson RJ,. Medulloblastoma: signalling a change in treatment. Lancet Oncol 2004; 5: 209 -18.
5. de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R,. Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro Oncol 2008; 10: 1040 -60.
6. Karajannis M, Allen JC, Newcomb EW,. Treatment of pediatric brain tumors. J Cell Physiol 2008; 217: 584 -9.
7. Gottardo NG, Gajjar A,. Chemotherapy for malignant brain tumors of childhood. J Child Neurol 2008; 23: 1149 -59.
8. Preston-Martin S, Staples M, Farrugia H, Giles G,. Primary tumors of the brain, cranial nerves and cranial meninges in Victoria. Australia, 1982-1990: patterns of incidence and survival. Neuroepidemiology 1993; 12: 270 -9.
9. Gurney JG, Kadan-Lottick N,. Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 2001; 13: 160 -6.
10. Huppmann AR, Orenstein JM, Jones RV,. Cerebellar medulloblastoma in the elderly. Ann Diagn Pathol 2009; 13: 55 -9.
11. Prados MD, Warnick RE, Wara WM, Larson DA, Lamborn K, Wilson CB,. Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995; 32: 1145 -52.
12. Weil MD, Lamborn K, Edwards MS, Wara WM,. Influence of a child's sex on medulloblastoma outcome. JAMA 1998; 279: 1474 -6.
13. Curran EK, Sainani KL, Le GM, Propp JM, Fisher PG,. Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry. Pediatr Blood Cancer 2009; 52: 60 -4.
14. Belgorosky A, Rivarola MA,. Progressive increase in nonsex hormone-binding globulin-bound testosterone and estradiol from infancy to late prepuberty in girls. J Clin Endocrinol Metab 1988; 67: 234 -7.
15. Ikegami S, Moriwake T, Tanaka H, Inoue M, Kubo T, Suzuki S, Kanzakili S, Seino Y,. An ultrasensitive assay revealed age-related changes in serum oestradiol at low concentrations in both sexes from infancy to puberty. Clin Endocrinol 2001; 55: 789 -95.
16. Pazzaglia S, Mancuso M, Atkinson MJ, Tanori M, Rebessi S, Di Majo V, Covelli V, Hahn H, Saran A,. High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene 2002; 21: 7580 -4.
17. Pazzaglia S, Tanori M, Mancuso M, Gessi M, Pasquali E, Leonardi S, Oliva MA, Rebessi S, Di Majo V, Covelli V, Giangaspero F, Saran A,. Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice. Oncogene 2006; 25: 5575 -80.
18. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A,. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 1998; 4: 619 -22.
19. Mancuso M, Pazzaglia S, Tanori M, Hahn H, Merola P, Rebessi S, Atkinson MJ, Di Majo V, Covelli V, Saran A,. Basal cell carcinoma and its development: insights from radiation induced tumors in Ptch1 deficient mice. Cancer Res 2004; 64: 934 -41.
20. Mancuso M, Leonardi S, Tanori M, Pasquali E, Pierdomenico M, Rebessi S, Di Majo V, Covelli V, Pazzaglia S, Saran A,. Hair cycle-dependent basal cell carcinoma tumorigenesis in Ptc1neo67/+ mice exposed to radiation. Cancer Res 2006; 66: 6606 -14.
21. Qin J, Suh JM, Kim BJ, Yu CT, Tanaka T, Kodama T, Tsai MJ, Tsai SY,. The expression pattern of nuclear receptors during cerebellar development. Dev Dyn 2007; 2363: 810 -20.
22. Cardona-Gamez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM,. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev 2001; 37: 320 -34.
23. Del Valle L, Enam S, Lassak A, Wang JY, Croul S, Khalili K, Reiss K,. Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res 2002; 8: 1822 -30.
24. Kenney AM, Cole MD, Rowitch DH,. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 2003; 130: 15 -28.
25. Price RH, Jr, Handa RJ,. Expression of estrogen receptor-beta protein and mRNA in the cerebellum of the rat. Neurosci Lett 2000; 288: 115 -18.
26. Ikeda Y, Nagai A,. Differential expression of the estrogen receptors alpha and beta during postnatal development of the rat cerebellum. Brain Res 2006; 1083: 39 -49.
27. Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, Pfaff DW, Ogawa S, Rohrer SP, Schaeffer JM, McEwen BS, Alves SE,. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003; 144: 2055 -67.
28. Urbanska K, Pannizzo P, Lassak A, Gualco E, Surmacz E, Croul S, Del Valle L, Khalili K, Reiss K,. Estrogen receptor beta-mediated nuclear interaction between IRS-1 and Rad51 inhibits homologous recombination directed DNA repair in medulloblastoma. J Cell Physiol 2009; 219: 392 -401.
29. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H,. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001; 61: 2537 -41.
30. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001; 61: 5331 -5.
31. Lazennec G,. Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett 2006; 231: 151 -7.
32. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW,. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000; 60: 245 -8.
33. Mancuso M, Gallo D, Leonardi S, Pierdomenico M, Pasquali E, De Stefano I, Rebessi S, Tanori M, Scambia G, Di Majo V, Covelli V, Pazzaglia S, et al. Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer. Carcinogenesis 2009; 30: 340 -7.
34. de Giorgi V, Mavilia C, Massi D, Gozzini A, Aragona P, Tanini A, Sestini S, Paglierani M, Boddi V, Brandi ML, Lotti T,. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study. Arch Dermatol 2009; 145: 30 -6.
35. Matthews J, Gustafsson JA,. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003; 3: 281 -92.
36. Guessous F, Li Y, Abounader R,. Signaling pathways in medulloblastoma. J Cell Physiol 2008; 217: 577 -83.
37. Saran A,. Medulloblastoma: role of developmental pathways, DNA repair signaling, and other players. Curr Mol Med 2009; 9: 1046 -57.
38. Rao G, Pedone CA, Valle LD, Reiss K, Holland EC, Fults DW,. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004; 23: 6156 -62.
39. Del Valle L, Enam S, Lassak A, Wang JY, Croul S, Khalili K, Reiss K,. Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res 2002; 8: 1822 -30.
40. de Bont JM, van Doorn J, Reddingius RE, Graat GH, Passier MM, den Boer ML, Pieters R,. Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients. Int J Cancer 2008; 123: 594 -600.
41. Mendez P, Wandosell F, Garcia-Segura LM,. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front Neuroendocrinol 2006; 27: 391 -403.
42. Belcher SM, Ma X, Le HH,. Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma. Endocrinology 2009; 150: 1112 -21.
43. Plunkett RJ, Lis A, Barone TA, Fronckowiak MD, Greenberg SJ,. Hormonal effects on glioblastoma multiforme in the nude rat model. J Neurosurg 1999; 90: 1072 -7.
44. Barone TA, Gorski JW, Greenberg SJ, Plunkett RJ,. Estrogen increases survival in an orthotopic model of glioblastoma. J Neurooncol 2009; 95: 37 -48.